Research Article

Analysis of the Influencing Factors of Tumor Volume, Body Immunity, and Poor Prognosis after 125I Particle Therapy for Differentiated Thyroid Cancer

Table 6

Risk factors related to the efficacy of 125I particle treatment analyzed by multivariate logistic regression analysis.

FactorsSEWaldOR95% CI

Follicular adenocarcinoma0.9850.26312.2180.0012.7181.469~4.852
Tumor  cm1.2360.3185.0060.0013.4212.052~5.526
Clinical stage of III~IV1.1810.2836.7750.0013.2831.562~6.571
Distant metastasis0.8600.3635.1360.0022.3591.182~4.203
TSH 0.9520.4135.7500.0012.5231.409~4.853

Note: TSH: thyroid-stimulating hormone.